anti-myostatin peptide (PeptiDream/Kawasaki Medical School)

N/A

Report date: 2025/03/18 18:06:24

Base Information

Drug Nameanti-myostatin peptide (PeptiDream/Kawasaki Medical School)
Drug Alias Namemyostatin inhibitor (PeptiDream/Kawasaki Medical School)
ClassificationBiologics > Protein drugs > Recombinant polypeptide
Mechanisms of ActionGrowth/differentiation factor 8 inhibitors
TargetsGrowth/differentiation factor 8
Therapy Area/IndicationsObesityNeuromuscular DiseasesMuscular Atrophy, Spinal +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryJapan
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesKawasaki Medical School
China Registration ClassN/A

Develop Information

Active CompaniesPeptiDream IncKawasaki Medical School
Inactive CompaniesN/A
Active IndicationsObesityNeuromuscular DiseasesMuscular Atrophy, Spinal +[4] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A